Back to search results

Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia

Abroad (travel likely)RecruitingPHASE4

Conditions

Staphylococcus Aureus Endocarditis · Staphylococcus Aureus Septicemia · Staphylococcus Aureus Bloodstream Infection

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • McGill University Health Centre (Royal Victoria Hospital and Montreal General Hospital), Montreal, Quebec, Canada

    Contact: Study coordinator (Lina Petrella) · lina.petrella@muhc.mcgill.ca · 514-934-1934
    Contact: Principal Investigator (Todd C Lee, MD MPH FIDSA)
    Contact: Principal Investigator (Emily G McDonald, MD MSc)
    Matthew P. Cheng, MD SM (Sub-investigator)
    Patrick Lawler, MD MPH (Sub-investigator)
    Alexander Lawandi, MD MSc (Sub-investigator)
Study leads

  • Todd C Lee, MD MPH FIDSA

    Principal Investigator

    Research Institute of the McGill University Health Centre

  • Emily G McDonald, MD MSc

    Principal Investigator

    Research Institute of the McGill University Health Centre

View source on ClinicalTrials.gov(opens in a new tab)